Reply to A. Shinde et al

J Clin Oncol. 2019 Apr 20;37(12):1031-1032. doi: 10.1200/JCO.18.02463. Epub 2019 Feb 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Brain Neoplasms*
  • Humans
  • Melanoma*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab